Imagine a tiny, flexible electronic patch for the brain that acts like a smart thermostat, adjusting its stimulation in real-time based on what the patient needs. Instead of bulky wires and large incisions, it uses ultra-thin graphene and a robotic arm to be placed through a single small hole in the skull. This makes the process much gentler on the body and far more precise in treating brain disorders.
Current brain implants are too invasive, cause off-target side effects, and lack the ability to adapt to a patient's real-time needs.
A system comprising high-density graphene microelectrode arrays, a flexible electronics unit for the skull, and a robotic implantation method.
If you are a hardware developer dealing with low signal resolution and off-target stimulation in current DBS devices — this project developed high-density graphene microelectrode arrays that provide larger spatial resolution and better biocompatibility.
If you are a robotics firm dealing with the high invasiveness of traditional brain surgery — this project developed a minimally invasive implantation procedure that allows high precision through a single small skull incision.
If you are a software provider dealing with the lack of personalized therapies for Parkinson's — this project developed closed-loop neuromodulation capabilities that enable adaptive therapies based on individual patient needs.
Based on available project data, specific cost or pricing information is not provided.
The project is currently in the development and validation phase, aiming to demonstrate functionality; industrial scaling details are not specified in the provided data.
Based on available project data, the specific IP or licensing terms are not mentioned, though the project involves a consortium of 8 partners including SMEs.
It reduces invasiveness by using a single small skull incision and increases precision through a robotic implantation procedure.
The project period runs from 2022-10-01 to 2026-06-30, suggesting the validation phase concludes in mid-2026.
The consortium is well-balanced for a translation project, consisting of 8 partners across 6 countries. With a 25% industry ratio (including 2 SMEs), the project blends academic research from 3 universities and 3 research centers with commercial agility, specifically targeting expertise in robotic surgery and advanced neuromodulation.
Contact Fundacio Institut Catala de Nanociencia i Nanotecnologia in Spain
Contact us to explore licensing opportunities for graphene-based neural interfaces.
